About Conference

Sessions & Tracks

Track 01: Rare Diseases

Any illness that affects a very small percentage of the population is considered rare. Rare diseases include uncommon cancers, such as childhood cancers, as well as certain other well-known disorders, such as cystic fibrosisCF, pancreatic fibrosis, mucoviscididosis, fibrosis, and monogenic disorder. Huntington's disease and monogenic disease. The vast majority of rare infections can affect everyone, but some only affect a small number of people or even just one. This is the situation with Mediterranean anaemia, a hereditary anaemia that is common in the Mediterranean region but rare elsewhere. Numerous rare diseases first manifest in childhood. For a number of uncommon disorders, the exact cause is still unknown. however Environmental variables, microbial infections, genetic mutations, food, smoking, and chemical exposure also have an impact.

• Allergies
• Chromosome disorders affecting any body organ

Track 02: Infectious Diseases

Unusually, several words are used to describe infectious diseases. An infectious disease is an ailment brought on by an organism, and illness is the presence of pathology. The ability of an organism to cause illness in a given host is referred to as virulence. The level of the host's resistance to a specific germ is referred to as immunity. Vaccines prevent various infectious diseases, including varicella and morbilli. You can contract a communicable disease in a number of different ways, such as by bites from an animal or bug, tainted food, or polluted water. Babies born to expectant women will also contract certain germs from them; infectious disorders are normally distinguished by the primary organ system involved.

• Acanthamoeba keratitis.
• Scarlet fever

Track 03: Rare Cancer Diseases

Rare cancers affect an incredibly small population of people. If a cancer begins in a unique location within the body, it may also be regarded as rare. Or if the cancer is a rare type that requires specialised care and is brought on by ad hoc changes in the body. Experts are unsure of what causes the mutation. Since many people may not exhibit symptoms until later stages, regular blood tests are all that is needed to make the identification. When symptoms do appear, they include fatigue or a sensation of exhaustion, loss of weight, pale skin, and nocturnal sweats. These illnesses harm the bones, kidneys, system, and red blood cell count.

• Angiosarcoma
• Alveolar soft part sarcoma
• Chondrosarcoma

Track 04: Treatment for Rare Diseases

As eighty percent of rare diseases are caused by a single sequence and gene medical treatment has the potential to repair several genetic abnormalities, it is one of the reasonable strategies to treat rare sequencetic disorders. Restore one sequence defect by introducing a "right" sequence. Additionally, womb-to-tomb improvement may require only a single dosage of outstanding sequence medical therapy. Misuse of antisense medicine is one of our personal methods for treating rare diseases, and it mostly relies on ribonucleic acid for medication delivery. Treatment for uncommon disorders using live cells injected into the patient for therapeutic effect is known as cell medicine.

• Rexin G
• Carmustine
• Nanotechnology and Nano-medicine

Track 05: Rare paediatrics Diseases

Rare paediatric illnesses, which can be serious or fatal, affect people from birth to age 18, including the age groups often known as neonates, babies, children, and adolescents. One example of a paediatric rare disease is achondrogenesis. Due to increased public awareness, significantly improved understanding and treatment of the relatively many common disorders, the elimination of biological process deficiencies, and the subsequent development of laws related to the treatment of rare diseases, paediatric rare diseases have received excessive attention in recent years.

• Pediatric bruton agammaglobulinemia.
• Pediatric severe combined immunodeficiency

Track 06: Rare Skin Diseases

The majority of disorders that affect the skin start deep beneath its layers, and these anomalies are crucial in identifying a variety of internal diseases. The inherent region-specific anatomical variability of the skin can significantly alter how a rash appears. This becomes clear after skin is transplanted from one area of the body to another and still displays the morphological traits of the donor area. Hereditary skin illnesses are commonly categorised using gross morphological, histologic, and microscopic results; however, the precise diagnosis is frequently uncertain since skin diseases may not always appear in a recognisable way.

• Inverse psoriasis
• Harlequin ichthyosis

Track 07: Rare Diseases in Brain

The main link between brain illnesses and altered brain function or structure is this. this may be primarily due to seizures, state-of-mind, temperament changes, tumours, and infections. Jakob-Creutzfeldt disease (CJD) is an uncommon chronic brain disorder that is characterised by rapidly advancing medical conditions and severe symptoms. Once symptoms start, those who are impacted may experience disorientation, depression, changes in activity, reduced vision, and/or impaired coordination. As the illness worsens, vascular insanity results, which causes confusion and disorientation. More loss of cognitive and physical abilities, as well as tract infections such respiratory disease, may occur in later stages of the illness.

• Gerstmann-Straussler-Scheinker unwellness
• Amyotrophic lateral induration
• Creutzfeldt-jakob unwellness

Track 08: Rare Genetic Diseases

Rare genetic diseases ar caused by one or a lot of abnormalities within the ordination. it should be caused thanks to mutation in a very single sequence or multiple genes. However, there aren't any proverbial treatments for genetic disorders. several genetic disorders influence stages of development like Down's syndrome, whereas others end in physical symptoms like hereditary condition. thanks to the wide selection of genetic disorders, identification is wide varied and looking on the disorder. sequence medical care refers to at least one of the treatment wherever a healthy sequence is introduced to a patient. this could scale back the defect caused by a faulty sequence or slow the progression of the unwellness

• Albinism
• Angelman syndrome

Track 09: Rare hematology Diseases

RBC beta monogenic disorder, Diamond-Blackfan anaemia, and other anemia-type red vegetative cell conditions, white vegetative cell dysfunctions associated with various malignancies, and immuno-protoplasm-based abnormalities that affect platelet and lymphocyte disorders are just a few examples of the diverse subcategories of rare medical specialty diseases. Some rare blood illnesses, particularly those that are gene-based, can be distinguished with ease with a simple test, whilst others require substantial research to be properly analysed. Haematologists are skilled practitioners because they must be experts in differential diagnosis due to the wide diversity of blood diseases, both common and extraordinary.

• Myelofibrosis
• Polycythemia vera
• Aplastic Anemia

Track 10: Rare Diseases analysis

Due to the rarity and variety of rare infections, research must be conducted globally to ensure that experts, researchers, and doctors are connected and that clinical trials are conducted internationally so that patients can benefit from the pooling of resources across borders. Patients with rare illnesses still have to endure lengthy wait times in the healthcare system before a firm diagnosis is made. Analysis of rare infections is essential since many patients still need the right diagnosis and related treatments, and because experience in this field is very scarce.

Track 11: Rare response Diseases

In later years, national and international associations are established to inform and protect patients affected by these ailments. Rare infections caused by systemic changes represent a field of life science that is very interesting and is constantly expanding. These disorders have a ludicrous social and economic impact because they typically affect young or severely ill children who are at the height of their social activities and relationships. An hereditary condition may cause a malfunction of bone formation that prevents animal tissue from continuously converting to bone. It is distinguished by genetic abnormalities, limited elbow range of motion, and conventional intellect. The majority of inherited diseases are not contagious. World Health Organization estimates that about 80% of people have an inherited disease.

Track 12: Orphan medicine

Orphan drugs are a group. The medical product designated to treat rare diseases or unusual disorders and intended for the treatment, obstructing, or designation of a rare sickness or condition are called as "orphan medications" due to their niche markets. According to the definition of an orphan disease, it only affects 200,000 people nationwide. The majority of orphan diseases have a genetic basis. One in fifteen people could be affected by an orphan disease worldwide.

• Cystic pathology
• Wilson’s illness

Track 13: Rare Endocrine Genetic Diseases

There are numerous rare disorders of the body. According to the National Organization of Eudaimonia, over 175 different rare diseases affect the system, a complex system of organs and glands that uses about 30 different hormones to affect a variety of vital functions, including growth, metabolism, heart function, and fertility. Addison's disease is extremely rare. However, any organ system may likely be affected by rare endocrine illnesses.

Track 14: Clinical analysis and Treatment

Rare diseases provide unique chances to explore human physiology and life science. major scientific discoveries as a result of research on uncommon diseases. In order to share the findings of their research and advance more successfully, researchers are working through networks more and more frequently. The gratification of correctly diagnosing a patient with a rare sickness is frequently swiftly offset by the notion that the patient's condition can only be known about and treated to a limited extent due to its nature and, consequently, the challenges of learning the illness. A pharmaceutical product created for the treatment of uncommon disorders may be considered an associate orphan medication. Science will provide some solutions for all rare ailments.

Track 15: Mystery designation of Rare Diseases

The prevalence of rare diseases is between 2 and 4%. Children between the ages of 3 and 5 are most at risk. Eighty percent of uncommon illnesses are genetic in character, therefore ordination sequencing-based designation offers an encouraging alternative for the management of rare diseases. Mystery designation for rare diseases is entire ordination sequencing. By analysing many genes, ordination sequencing, which has a diagnosis rate of 62.5%, will be utilised to analyse rare and unknown illnesses in order to identify the relevant 

Track 16: Neglected Tropical Diseases

The group of parasitic and microbial infections known as neglected tropical diseases affects nearly one billion people worldwide and costs poor nations' economies billions of dollars annually, including 836 million children. People typically have more than one parasite or contamination because "they are" or "they are" frequently grouped together geographically. Once selected open eudaimonia approaches are combined and disseminated locally, palmy management will be accomplished. Trade is influenced by the local medical specialty and the availability of appropriate treatments to recognize, anticipate, and manage illnesses. Multiple tropical diseases will be anticipated, treated, or eliminated thanks to newly developed advancements in safe and effective technology. Management relies on straightforward mediations.

Market Analysis

Importance & Scope:

There are more than 7,000 classified rare diseases and 70% of them have no type of treatment, there are extensive neglected needs around there. Administrative advantages, for example, longer market selectiveness, leap forward assignments, diminished expenses and assessment motivators are all reassuring speculation.

World Rare Diseases 2019 will be the best platform for all the specialists and super specialists, renowned Scientists, research scholars, students who are working in this field across the globe under a single place to exchange their knowledge on rare diseases. This event is an effort to find an alternative for invasive imaging technique against diseases like haemophilia, cystic fibrosis, lupus, motor neurone disease, acromegaly, Fragile X syndrome, Gaucher’s disease and Gorlin’s syndrome, as well as many others. These diseases often referred to as orphan diseases. Affect only a small portion of the population .The number of diseases for which no treatment is currently available is estimated to be between 4,000 to 5,000 worldwide. Orphan drugs are medicinal products which are used for the treatment of diseases or conditions which affect a very small portion of the population which are known to be rare diseases like infectious diseases, Genetic Diseases and Etc. 

Impact of Rare Diseases  

Rarity is an attribute which finds contextual appreciation or criticism. A rare gem could be an object of utmost desire, but a rare genetic mutation which translates into the rare, incurable disease is not. A disease which shows particularly low prevalence as it affects a small number of individuals in a population classifies as a rare or orphan disease. Such diseases are yet to be captured in a single universal definition, as defining these diseases is a complex issue. It is because these diseases show symptomatic heterogeneity, influenced by the socioeconomic and demographic condition of the patient as well. Most of the definitions are therefore based on prevalence estimates, undermining the factors of geographic location, level of rarity.

Success probabilities for Rare Diseases vs. All Diseases  

Most of the rare diseases are already recognized and their diagnosis is also there, while technological progresses made it simpler to identify rare diseases and develop the complex biological molecules often required to treat them. Now a day’s rare disease are not so rare.